Treatment for Adderall Overdose
Management of Adderall overdose is largely symptomatic and supportive, with benzodiazepines as the cornerstone for controlling the sympathomimetic syndrome, including agitation, seizures, and cardiovascular effects. 1
Initial Management and Decontamination
- Consult a Certified Poison Control Center immediately for up-to-date guidance on acute amphetamine intoxication 1
- Perform gastric lavage if presentation is within 1-2 hours of ingestion 1
- Administer activated charcoal to reduce drug absorption 1
- Give a cathartic agent to enhance gastrointestinal elimination 1
Clinical Presentation to Anticipate
The sympathomimetic syndrome from Adderall overdose presents with:
- Neurological effects: Restlessness, tremor, hyperreflexia, confusion, agitation, combative behavior, hallucinations, panic states, delirium, anxiety, paranoia, movement disorders, and seizures 1, 2
- Cardiovascular effects: Tachycardia, arrhythmias, hypertension (or hypotension), and potential circulatory collapse 1, 2
- Other manifestations: Hyperpyrexia, rapid respiration, mydriasis, rhabdomyolysis, nausea, vomiting, diarrhea, and abdominal cramps 1, 2, 3
- Severe cases: Fatal poisoning is usually preceded by convulsions and coma 1
Pharmacologic Management Algorithm
First-Line: Benzodiazepines
- Use benzodiazepines as the primary intervention to interrupt the sympathomimetic syndrome, control agitation, prevent seizures, and reduce cardiovascular stress 2
- Administer in escalating doses until adequate sedation is achieved 2
Second-Line Agents (if benzodiazepines fail)
When agitation, delirium, and movement disorders are unresponsive to benzodiazepines:
- Antipsychotics: Ziprasidone or haloperidol 2
- Note: Chlorpromazine specifically antagonizes the central stimulant effects of amphetamines and can be used to treat amphetamine intoxication 1
- Central alpha-agonists: Dexmedetomidine 2
- Propofol for refractory cases 2
Cardiovascular Management
- For severe acute hypertension: Intravenous phentolamine has been suggested, though blood pressure usually drops gradually once adequate sedation is achieved 1
- For tachyarrhythmias: Beta-blockers such as propranolol can be used 3
- Monitor for myocardial infarction: Maintain high suspicion for cardiac ischemia, especially in patients presenting with chest pain and abnormal ECG, even in young patients without cardiovascular risk factors 4, 5
Critical Supportive Care Measures
- Intravenous fluids: Essential for managing hyperthermia, maintaining renal function (especially if rhabdomyolysis is present), and promoting amphetamine elimination 3
- Temperature control: Aggressive cooling measures for hyperpyrexia 2, 3
- Monitor for rhabdomyolysis: Check creatine kinase levels and urine myoglobin 1, 2
Controversial: Urinary Acidification
- Avoid urinary acidification despite increased amphetamine excretion because it increases the risk of acute renal failure if myoglobinuria is present from rhabdomyolysis 1
- This represents a shift from older practices that emphasized acidification 1
Hemodialysis Consideration
- Experience with hemodialysis or peritoneal dialysis is inadequate to permit routine recommendation for amphetamine overdose 1
- Reserve for severe cases with refractory symptoms or significant end-organ damage 1
Dose-Toxicity Relationship
- Toxic symptoms occasionally occur at doses as low as 2 mg (idiosyncratic), but are rare with doses less than 15 mg 1
- 30 mg can produce severe reactions 1
- Doses of 400-500 mg are not necessarily fatal, though individual response varies widely 1
- Fatalities are rare with appropriate intensive care, though major morbidity requiring ICU admission and prolonged hospitalization is common 2
Special Monitoring Considerations
- Secondary complications can involve renal failure, muscle breakdown, pulmonary effects, and gastrointestinal symptoms requiring specific monitoring 2
- Hypoglycemia, hypersegmentation of neutrophils, and mild thrombocytopenia have been reported in severe intoxications 3
- Concurrent alcohol use creates a particularly dangerous situation with serious cardiovascular adverse effects, including increased risk of myocardial infarction 4, 5
Common Pitfall to Avoid
Do not delay benzodiazepine administration while attempting other interventions—sedation is the foundation of treatment and often resolves cardiovascular complications without additional pharmacologic intervention 1, 2